Alnylam Pharmaceuticals
Develops novel therapeutics-based RNAi and provides overviews of recent drug development programs. Learn more
Launch date
Employees
Market cap
$33.6b
Enterprise valuation
$32.3b (Public information from Sep 2024)
Share price
$273.14999 ALNY
Cambridge Massachusetts (HQ)
Authorizing premium user...